The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Would surely have an IPO before then, they'll need punchy funding to start building factories. I rather expect it'll be a bit like biotech firms - once they've developed a drug big pharma often buys them. Similarly surely the big food producers are going to start snapping up people like BlueNalu when they've developed the know how. Wouldn't someone like Conagra buy it and build the factories for mass rollout?
Nutreco is one of the world’s largest fish feed companies and when BlueNalu brings its cell-based fish to market — hopefully within two years — Nutreco could serve as a supply chain partner for media ingredients. BlueNalu will need a lot of feed; in five years, BlueNalu plans to build a massive facility that will produce a whopping 18 million pounds of cell-based seafood per year.
BlueNalu interesting but ... "by the end of this decade."
Was hoping for IPO news or commercialisation before then
The 6% invested in BlueNalu has the potential to be just one major winner for Agronomics:
Lou Cooperhouse, President and CEO of BlueNalu, said, “The partnership with Nutreco is another significant milestone for BlueNalu, enabling our team to accelerate our path to commercialization while securing a global supply chain partner. We expect this to be of significant value to our company as our goal is to launch our seafood products in a test market over the next two years and launch them in several global markets by the end of this decade.”
Yes, thank you, and there are other supporting articles too
Is this the link you can't post ?
https://www.foodingredientsfirst.com/news/bluenalu-and-nutreco-collaboration-accelerates-global-commercialization-of-cellular-aquaculture.html
Clearly, I cannot post the link but here is one headline: BlueNalu and Nutreco collaboration accelerates global commercialization of cellular aquaculture
Great news we have been awaiting:
https://thespoon.tech/bluenalu-partners-with-nutreco-to-advance-cell-based-fish-feed/
This rise and the drop that preceded it is just market froth, the real movement will come when one of our holdings either IPOs or launches a consumer ready product. Could take a year or two but it will be well worth the wait.
Well the SP on the up again. Doesn’t seem to take much to move this. The premium to NAV is obviously not stopping some adding.
It doesn’t take much to rationalise the premium due to the fact that you are getting access to privately held companies who are operating at the bleeding edge of a potentially globally transformational technology. That puts the blue sky valuations at many multiples of their current funding rounds. The company also has a good cash balance on hand to add further to the portfolio and might even get some return on their legacy investments if we are fortunate.
Of course that comes with risk at the extreme end of the spectrum so it’s no surprise to see some either misinterpreting that or not seeing the risk / reward as being correctly balanced.
Each to their own I suppose but I’m firmly in the buy and hold camp here with a time horizon of a good 5 years at least.
Beardozer, waiting for a 7p offer that may never come has its own risks, it could mean paying significantly more than 9p in future.
Bear that in mind while considering an investment. But I'm not sure I agree with skier1's fair valuation of 2-4p. As Candid says the sooner the biotech investments are disposed of the better. Not all ANIC's investments will come good but I'm sure the few that do will make 9p seem like a bargain in years to come. But I'd rather be paying 6-7p now and I don't think 9p is a top-up opportunity.